Prof. Dr. Taner Akyo

A. Internationally published articles
1) Akyol T, Bulucu F, Sener O, Yamanel L, Aydin A, Inal V, Bozoglu E, Demirkaya E, Eken A, Musabak U. “Functions and oxidative stress status of leukocytes in patients with nephrotic syndrome ” Biol Trace Elem Res. 2007 Jun;116(3):237-48.
2) Akyol T, Tanoglu A, Yazgan Y, Cosar A, Berber U, Kaplan M.
“Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in patients with non-alcoholic fatty liver disease”. Disease and Molecular Medicine 2015;3: 11-17 DOI: 10.5455/dmm.20150424065705
3) Kaplan M, Tanoglu A, Serdar YS, Akyol T, Oncu K, Kara M, Yazgan Y.
“Landmark reading alterations in patients with gastro-oesophageal reflux symptoms undergoing diagnostic gastroscopy”Arab Journal of Gastroenterology 2016 Aug.
4) Ovalı O, Bagcı S, Baylan O, Kısa O, Kaya A, Karacalioğlu O, Ateş Y, Tuzunn A, Dagalp K, Akyol T, Ermiş F, Oncu K, Nazik H. “The role of CagA status on histological virulence , clinical presentation and eradication treatment outcomes in helicobacter pylori positive patients with functional dyspepsia,” Nobel Med 2012; 8(1): 52-60.
5) Ermis F, Ozel M, Oncu K, Yazgan Y, Demirturk L, Gurbuz AK, Akyol T, Nazik H. “Indications, complications and long-term follow-up of patients undergoing percutaneous endoscopic gastrostomy: A retrospective study,” Wien Klin Wochenschr. 2012 Mar;124(5-6):148-53. doi: 10.1007/s00508-011-0082-0.Epub2012Mar5.
6) Ermis F, Oncu K, Ozel M, Yazgan Y, Gurbuz AK, Demirturk L, Demirci H, Akyol T, Hahoglu A. “
Benign recurrent intrahepatic cholestasis: late initial diagnosis in adulthood,” Ann Hepatol. 2010 Apr-Jun;9(2):207-10.
7) I. Küçük, A. Tanoğlu, K. Öncü, İ. Yılmaz, M. Kara, Y. Beyazıt, T. Akyol, M. Kaplan, HO Özarı, Y. Yazgan. Immunohistochemical activity of Prohibitin-2 and Stomatin-Like Protein-2 in patients with ulcerative colitis. Turk J Gastroenterol 2016; 27:233-8.

B. Papers presented at international scientific meetings
1) Akyol T, Yazgan Y, Tanoğlu A, Kaplan M. “Evaluation of serum matrix metalloproteinases as a marker of non-alcoholic fatty liver disease,” Balkan Military Medical Review,156. 18th congress of Balkan Military Medical Committee, Istanbul, 22-26 May 2013, OP 88
2) Akyol T, Karagöz E, Yazgan Y. “The relationship between serum Fetuin-A and liver fibrosis in patients with non-alcoholic faty liver disease,” Hepatol int. (2015) 9 (suppl.1)s1-S391. 24th Annual Conference of APASL Marc 12-15,2015, Istanbul, Turkey
3) Tanoğlu A, Akyol T. “Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease,” Balkan Military Medical Review,2014;5 (suppl) e1-e322. 19th congress of Balkan Military Medical Committee, Plovdiv-Bulgaria 07-10 May 2014, PP-70.
4) T. Akyol, A.Tanoglu, U. Aydogan, O.Sari. “Evaluation of body parameters in patients with nonalcoholic fatty liver disease,” WONCA 2013 Prague, 20th World Conference. Prague, Czech Republic, 25–29 June 2013, P1149.
5) A. Tanoglu, T. Akyol, O. Sari, U. Aydogan. “Frequency of metabolic syndrom parameters in patients with nonalcoholic fatty liver disease (NAFLD),” WONCA 2013 Prague, 20th World Conference. Prague, Czech Republic, 25–29 June 2013, P1156.
6) O. Sari, A. Tanoglu, T. Akyol, U. Aydogan. “Evaluation of lipid profile in patients with non-alcoholic fatty liver disease (NAFLD),” WONCA 2013 Prague, 20th World Conference. Prague, Czech Republic, 25–29 June 2013, P1492.
7) A. Tanoglu, T. Akyol. “A rare chronic diarrhea related extraintestinal manifestation of severe disease: microscopic colitis, thymoma and myasthenia gravis,” 40th. ICMM World Congress on Military Medicine, Jeddah 7th-12th December 2013, 284

C. National publications
1) T. Duzenli, A.Tanoglu, T. Akyol, M. Kara, Y. Yazgan. Drug-induced Liver Injury Caused by Phenprobamate: Strong Probability Due to Repeated Toxicity. Euroasian Journal of Hepato-Gastroenterology, Volume 9 Issue 1 (January-June 2019)
2) Regular T, Tanoglu A, Akyol T, Kara M, Yazgan Y. Geriatric Celiac Disease: An Overlooked Diagnosis. TJFMPC, 2019;13(1): 100102. DOI: 10.21763/tjfmpc.528056

D. Papers presented at national scientific meetings and published in proceedings
ORAL PRESENTATIONS
1) Akyol T., Bulucu F., Yamanel L., Aydin A., Musabak U., Pekel A., Vural A., Ure M., Koçar İ.H. “Evaluation of the functions of polymorphonuclear leukocytes in adult nephrotic syndrome,” VII. National Hypertension and Kidney Diseases Congress, Antalya, 25-29 May 2005, Oral presentation, P15.

POSTER PAPERS
1) Öncü K, Özel A. M, Yazgan Y, Demirtürk L, Ermiş F, Gürbüz AK, Akyol T. “Evaluation of our seven-year percutaneous endoscopic gastrostomy results,” The Turkish Journal of Gastroenterology, 20 (suppl 1); 90. (26. National Gastroenterology Week, Ankara, 14-18 October 2009, P110.)
2) Öncü K, Özel A. M, Demirtürk L, Gürbüz AK, Yazgan Y, Kızılkaya E, Akyol T. “Dyssynergic in patients with functional constipation defecation frequency and patient characteristics,” The Turkish Journal of Gastroenterology, 19 (suppl 1); 77. (25. National Gastroenterology Week, Adana, 12-16 November 2008, PS-50.)
3) T. Akyol, Y. Yazgan, A. Tanoğlu, M. Kaplan. “Evaluation of matrix metalloproteinases as serum markers in nonalcoholic fatty liver disease with metabolic syndrome,” The Turkish Journal of Gastroenterology, 23 (suppl 1); 244. (29. National Gastroenterology Week, Antalya, 20-25 November 2012, PS-320.)
4) T. Akyol, A. Tanoğlu, M. Kaplan, İ. Yilmaz. “Early diagnosis of a systemic disease (amyloidosis) in upper GI endoscopy for treatment-resistant dyspepsia: a case report,” The Turkish Journal of Gastroenterology, 23 (suppl 1). (29. National Gastroenterology Week, Antalya, 20-25 November 2012, PS-147.)
5) T. Akyol, Y. Yazgan, A. Tanoğlu, M. Kaplan. “Evaluation of serum magnesium, uric acid and hsCRP levels as biochemical markers of fibrosis in nonalcoholic fatty liver disease,” The Turkish Journal of Gastroenterology, 23 (suppl 1). (29. National Gastroenterology Week, Antalya, 20-25 November 2012, PS-321.)
6) Cebeci İ, Özel A. M, Öncü K, Demirtürk L, Gürbüz AK, Yazgan Y, Akyol T. “In chronic hepatitis C patients Evaluation of pre-treatment parameters that may be effective in response to PEG-Interferon + Ribavirin treatment,” 7th National Hepatology Congress, İzmir, 10-13 June 2009, P111.
7) Ermiş F, Demirci H, Öncü K, Tangı F, Akyol T, Yazgan Y, Özel A. M, Gürbüz AK, Demirtürk L. “Benign recurrent intrahepatic cholestasis responsive to rifampicin; case report,” Antalya, 11th National Internal Medicine Congress, 30 September-4 October 2009, P229.
8) A. Tanoglu, T. Akyol. “A rare chronic diarrhea related extraintestinal manifestation of severe disease: microscopic colitis, thymoma and myasthenia gravis,” Famagusta, 10. National Hepato gastroenterology Congress, 25-29 September 2013, PS-133.
9) T. Akyol, A. Tanoglu, AS Kusat. “Foreign body that is rare in the gastrointestinal tract and requires surgical treatment: A case report,” Famagusta, 10th National Hepato-Gastroenterology Congress, 25-29 September 2013, TRNC, PS-132.
10) Ufuk Avcıoğlu, Taner Akyol Eosinophilic acid and 3-year follow-up. 35th National Gastroenterology Week 21-25 November 2018 EP:231.
11) Taner Akyol. Ufuk Avcıoğlu Development of Gastric Hyperplastic Polyps and Dysplasia Associated with Long-Term Proton Pump Inhibitor Use: A Case Report 35th National Gastroenterology Week 21-25 November 2018 EP-148.